{
  "abstract": "Self‐reported adverse events following first and second recombinant zoster vaccination (RZV) doses in older adults (n = 41,069) collected through AusVaxSafety were analysed. Adverse event rates were higher following Dose 2 (54%; 95% CI, 53%–54%) than after Dose 1 (45%; 95% CI, 45%–46%), particularly with 3–6‐ and 7–9‐month dose intervals, although medical review rates remained low (1.1%; 95% CI, 1.0%–1.2%), suggesting RZV is reactogenic but with no serious outcomes.",
  "abstract_shown": true,
  "affiliations": [
    "National Centre for Immunisation Research and Surveillance Sydney New South Wales Australia",
    "Children's Hospital Westmead Clinical School University of Sydney Sydney New South Wales Australia"
  ],
  "article_type": "brief report",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Lucy Dawes",
      "orcid": "0009-0000-2908-7363"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Thuy Nguyen",
      "orcid": "0000-0002-0558-8662"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Kristine Macartney",
      "orcid": "0000-0002-4675-0232"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Lucy Deng",
      "orcid": "0000-0003-0066-2218"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/e61m6qryce29a.bib",
  "cited_by": 0,
  "doi": "10.5694/mja2.70327",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13696965/",
  "id": "e61m6qryce29a",
  "issns": [
    "0025-729X",
    "1326-5377"
  ],
  "landing_url": "https://doi.org/10.5694/mja2.70327",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Environment and Public Health"
    ],
    [
      "heading",
      "Pharmaceutical Preparations"
    ],
    [
      "heading",
      "Research Letter"
    ],
    [
      "heading",
      "Statistics, Epidemiology and Research Design"
    ],
    [
      "openalex",
      "2713|Herpesvirus Infections and Treatments"
    ]
  ],
  "openalex": "W7223687057",
  "pdf_url": "https://europepmc.org/articles/PMC13696965?pdf=render",
  "pmcid": "PMC13696965",
  "pmid": "42928968",
  "published": "2026-10-26",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/e61m6qryce29a.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:18:13Z",
      "native_id": "PMC13696965",
      "source": "pmc",
      "url": "https://doi.org/10.5694/mja2.70327"
    },
    {
      "first_seen": "2026-10-30T12:21:18Z",
      "native_id": "MED:42928968",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42928968"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Herpesvirus Infections and Treatments",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Short‐Term Adverse Events Following Recombinant Zoster Vaccination in Older Adults in Australia: A Survey Study Comparing Dose 1 and Dose 2 and Influence of Dose Interval",
  "title_text": "Short‐Term Adverse Events Following Recombinant Zoster Vaccination in Older Adults in Australia: A Survey Study Comparing Dose 1 and Dose 2 and Influence of Dose Interval",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:34:12Z",
  "url": "https://research.draconitic.com/paper/e61m6qryce29a",
  "venue": "The Medical Journal of Australia",
  "versions": []
}